| Medical and Health Sciences | 2021-2025 | 523 | CH 8 | 99.89 |
| Pathology and Forensic Medicine | Lifetime | 44 | CH 1 | 99.83 |
| Pulmonary and Respiratory Medicine | Lifetime | 758 | CH 14 | 98.85 |
| Rheumatology | Lifetime | 704 | CH 12 | 96.44 |
| Dermatology | Lifetime | 598 | CH 14 | 94.79 |
| Pathology and Forensic Medicine | 2021-2025 | 10 | CH 1 | 99.74 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 196 | CH 5 | 98.53 |
| Epidemiology | 2021-2025 | 960 | CH 9 | 90.01 |
| Rheumatology | 2021-2025 | 295 | CH 5 | 89.92 |
| Dermatology | 2021-2025 | 283 | CH 5 | 85.56 |
| Immunology | 2021-2025 | 653 | CH 14 | 80.56 |
| Systemic Sclerosis and Related Diseases | Lifetime | 4 | CH 1 | 99.85 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 28 | CH 1 | 99.74 |
| Mast cells and histamine | Lifetime | 18 | CH 1 | 99.49 |
| Dermatologic Treatments and Research | Lifetime | 17 | CH 1 | 99.65 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 21 | CH 1 | 99.49 |
| Connective Tissue Growth Factor Research | Lifetime | 7 | CH 1 | 99.21 |
| Eosinophilic Disorders and Syndromes | Lifetime | 97 | CH 2 | 99.05 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 150 | CH 2 | 99.06 |
| Autoimmune Bullous Skin Diseases | Lifetime | 98 | CH 2 | 98.92 |
| Extracellular vesicles in disease | Lifetime | 665 | CH 6 | 95.31 |
| Skin Diseases and Diabetes | Lifetime | 121 | CH 3 | 96.45 |
| Vascular Anomalies and Treatments | Lifetime | 281 | CH 6 | 93.71 |
| Fibroblast Growth Factor Research | Lifetime | 829 | CH 13 | 90.96 |
| Dermatological and Skeletal Disorders | Lifetime | 628 | CH 11 | 89.72 |
| Dupuytren's Contracture and Treatments | Lifetime | 303 | CH 12 | 84.88 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 2 | CH 1 | 99.81 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 15 | CH 1 | 99.63 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 9 | CH 1 | 99.40 |
| Dermatologic Treatments and Research | 2021-2025 | 15 | CH 1 | 98.65 |
| Mast cells and histamine | 2021-2025 | 39 | CH 2 | 95.94 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 160 | CH 2 | 96.21 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 242 | CH 4 | 92.38 |
| Connective Tissue Growth Factor Research | 2021-2025 | 15 | CH 1 | 88.61 |
| Skin Diseases and Diabetes | 2021-2025 | 46 | CH 1 | 86.27 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 277 | CH 9 | 89.05 |
| Vascular Anomalies and Treatments | 2021-2025 | 81 | CH 2 | 86.66 |
| Urticaria and Related Conditions | 2021-2025 | 803 | CH 14 | 77.39 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 562 | CH 13 | 74.80 |
| Hematological disorders and diagnostics | 2021-2025 | 861 | CH 21 | 50.82 |
| Dermatological and Skeletal Disorders | 2021-2025 | 891 | CH 8 | 36.67 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 347 | CH 8 | 15.77 |
